Toxicity of TiO(2) Nanoparticles: Validation of Alternative Models

There are many studies concerning titanium dioxide (TiO(2)) nanoparticles (NP) toxicity. Nevertheless, there are few publications comparing in vitro and in vivo exposure, and even less comparing air–liquid interface exposure (ALI) with other in vitro and in vivo exposures. The identification and validation of common markers under different exposure conditions are relevant for the development of smart and quick nanotoxicity tests. In this work, cell viability was assessed in vitro by WST-1 and LDH assays after the exposure of NR8383 cells to TiO(2) NP sample. To evaluate in vitro gene expression profile, NR8383 cells were exposed to TiO(2) NP during 4 h at 3 cm(2) of TiO(2) NP/cm(2) of cells or 19 μg/mL, in two settings—submerged cultures and ALI. For the in vivo study, Fischer 344 rats were exposed by inhalation to a nanostructured aerosol at a concentration of 10 mg/m(3), 6 h/day, 5 days/week for 4 weeks. This was followed immediately by gene expression analysis. The results showed a low cytotoxic potential of TiO(2) NP on NR8383 cells. Despite the absence of toxicity at the doses studied, the different exposures to TiO(2) NP induce 18 common differentially expressed genes (DEG) which are involved in mitosis regulation, cell proliferation and apoptosis and inflammation transport of membrane proteins. Among these genes, we noticed the upregulation of Ccl4, Osm, Ccl7 and Bcl3 genes which could be suggested as early response biomarkers after exposure to TiO(2) NP. On the other hand, the comparison of the three models helped us to validate the alternative ones, namely submerged and ALI approaches.